Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AVACTA-GROUP-PLC-26123500/news/Avacta-notes-excellent-safety-profile-for-prospective-sarcoma-drug-44876306/?utm_source=whatsapp&utm_medium=social&utm_campaign=share